• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚患者中溃疡分枝杆菌病的自发愈合。

Spontaneous healing of Mycobacterium ulcerans disease in Australian patients.

机构信息

Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.

Department of Medicine and Infectious Diseases, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.

出版信息

PLoS Negl Trop Dis. 2019 Feb 19;13(2):e0007178. doi: 10.1371/journal.pntd.0007178. eCollection 2019 Feb.

DOI:10.1371/journal.pntd.0007178
PMID:30779807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6396929/
Abstract

BACKGROUND

Mycobacterium ulcerans causes necrotising infections of skin and soft tissue mediated by the polyketide exotoxin mycolactone that causes cell apoptosis and immune suppression. It has been postulated that infection can be eradicated before the development of clinical lesions but spontaneous resolution of clinical lesions has been rarely described.

METHODOLOGY/PRINCIPAL FINDINGS: We report a case series of five Australian patients who achieved healing of small M. ulcerans lesions without antibiotics or surgery. The median age of patients was 47 years (IQR 30-68 years) and all patients had small ulcerative lesions (median size 144mm2, IQR 121-324mm2). The median duration of symptoms prior to diagnosis was 90 days (IQR 90-100 days) and the median time to heal from diagnosis without treatment was 68 days (IQR 63-105 days). No patients recurred after a median follow-up of 16.6 months (IQR 16.6-17.9 months) from the development of symptoms and no patients suffered long-term disability from the disease.

CONCLUSIONS

We have shown that healing without specific treatment can occur for small ulcerated M. ulcerans lesions suggesting that in selected cases a robust immune response alone can cure lesions. Further research is required to determine what lesion and host factors are associated with spontaneous healing, and whether observation alone is an effective and safe form of management for selected small M. ulcerans lesions.

摘要

背景

溃疡分枝杆菌引起皮肤和软组织的坏死性感染,由聚酮外毒素分枝杆菌内酯介导,导致细胞凋亡和免疫抑制。有人假设在出现临床病变之前可以消除感染,但很少有自发缓解临床病变的描述。

方法/主要发现:我们报告了五例澳大利亚患者的病例系列,这些患者在没有使用抗生素或手术的情况下治愈了小的溃疡分枝杆菌病变。患者的中位年龄为 47 岁(IQR 30-68 岁),所有患者均有小的溃疡性病变(中位大小为 144mm2,IQR 121-324mm2)。从诊断到治愈的中位时间为 68 天(IQR 63-105 天),没有患者在症状出现后 16.6 个月(IQR 16.6-17.9 个月)的中位随访时间内复发,也没有患者因该疾病而长期残疾。

结论

我们已经表明,未经特定治疗即可治愈小的溃疡性溃疡分枝杆菌病变,这表明在某些情况下,强大的免疫反应本身就可以治愈病变。需要进一步研究确定哪些病变和宿主因素与自发愈合有关,以及单独观察是否是治疗选定的小溃疡分枝杆菌病变的有效和安全方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db2/6396929/681957766047/pntd.0007178.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db2/6396929/2c0d03454b64/pntd.0007178.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db2/6396929/681957766047/pntd.0007178.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db2/6396929/2c0d03454b64/pntd.0007178.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db2/6396929/681957766047/pntd.0007178.g002.jpg

相似文献

1
Spontaneous healing of Mycobacterium ulcerans disease in Australian patients.澳大利亚患者中溃疡分枝杆菌病的自发愈合。
PLoS Negl Trop Dis. 2019 Feb 19;13(2):e0007178. doi: 10.1371/journal.pntd.0007178. eCollection 2019 Feb.
2
Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.创伤愈合:澳大利亚分枝杆菌溃疡病患者接受抗生素治疗时延迟愈合的自然史和危险因素。
PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006357. doi: 10.1371/journal.pntd.0006357. eCollection 2018 Mar.
3
Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.老年人群中的溃疡分枝杆菌:病情更严重且预后欠佳。
PLoS Negl Trop Dis. 2015 Dec 2;9(12):e0004253. doi: 10.1371/journal.pntd.0004253. eCollection 2015 Dec.
4
Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area.澳大利亚人群中溃疡分枝杆菌水肿性皮损的临床特征及危险因素:在地方病流行区需警惕蜂窝织炎
PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2612. doi: 10.1371/journal.pntd.0002612. eCollection 2014.
5
Six vs Eight Weeks of Antibiotics for Small Mycobacterium ulcerans Lesions in Australian Patients.六周与八周抗生素疗程治疗澳大利亚患者小分枝杆菌性溃疡病变的疗效比较。
Clin Infect Dis. 2020 Apr 15;70(9):1993-1997. doi: 10.1093/cid/ciz532.
6
Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients.澳大利亚患者治疗溃疡分枝杆菌病期间的抗生素并发症。
Intern Med J. 2017 Sep;47(9):1011-1019. doi: 10.1111/imj.13511.
7
Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model.几内亚猪模型中溃疡分枝杆菌病变的自发愈合
PLoS Negl Trop Dis. 2015 Dec 1;9(12):e0004265. doi: 10.1371/journal.pntd.0004265. eCollection 2015 Dec.
8
FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.FVB/N小鼠可自发愈合由溃疡分枝杆菌诱导产生的溃疡性病变,并使溃疡分枝杆菌转变为产低水平分枝杆菌内酯的菌株。
J Immunol. 2016 Mar 15;196(6):2690-8. doi: 10.4049/jimmunol.1502194. Epub 2016 Feb 12.
9
Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection.贝宁骨髓炎患者的研究结果和聚合酶链反应确认的溃疡分枝杆菌感染。
Clin Infect Dis. 2014 Nov 1;59(9):1256-64. doi: 10.1093/cid/ciu584. Epub 2014 Jul 21.
10
Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.溃疡分枝杆菌病抗生素治疗期间人皮下组织中分枝杆菌内酯的动力学
BMC Infect Dis. 2014 Apr 15;14:202. doi: 10.1186/1471-2334-14-202.

引用本文的文献

1
A human model of Buruli ulcer: Provisional protocol for a controlled human infection study.布鲁里溃疡人体模型:一项对照人体感染研究的临时方案。
Wellcome Open Res. 2024 Oct 21;9:488. doi: 10.12688/wellcomeopenres.22719.1. eCollection 2024.
2
A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strain.人体布鲁里溃疡模型:人为感染控制的案例和选择溃疡分枝杆菌挑战株的考虑因素。
PLoS Negl Trop Dis. 2023 Jun 29;17(6):e0011394. doi: 10.1371/journal.pntd.0011394. eCollection 2023 Jun.
3
Mycobacterium ulcerans culture results according to duration of prior antibiotic treatment: A cohort study.

本文引用的文献

1
Mycobacterium ulcerans disease management in Australian patients: the re-emergence of surgery as an important treatment modality.澳大利亚患者的溃疡分枝杆菌病管理:手术作为一种重要治疗方式的再度兴起。
ANZ J Surg. 2019 Jun;89(6):653-658. doi: 10.1111/ans.14829. Epub 2018 Sep 21.
2
Low incidence of recurrent Buruli ulcers in treated Australian patients living in an endemic region.在流行地区治疗的澳大利亚患者中复发性布鲁里溃疡的发病率较低。
PLoS Negl Trop Dis. 2018 Aug 13;12(8):e0006724. doi: 10.1371/journal.pntd.0006724. eCollection 2018 Aug.
3
Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response.
分枝杆菌溃疡培养结果根据先前抗生素治疗的持续时间:一项队列研究。
PLoS One. 2023 Apr 24;18(4):e0284201. doi: 10.1371/journal.pone.0284201. eCollection 2023.
4
The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.逃之夭夭:分枝杆菌酸依赖的 Sec61 阻断如何使巨噬细胞衍生的白细胞介素 1β逃脱。
Front Immunol. 2022 Jan 26;12:788146. doi: 10.3389/fimmu.2021.788146. eCollection 2021.
5
High antibody titres induced by protein subunit vaccines using antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice.使用热休克蛋白18(Hsp18)和MUL_3720抗原以及Toll样受体2(TLR-2)激动剂的蛋白质亚单位疫苗诱导产生的高抗体滴度不能保护小鼠免受布鲁里溃疡感染。
PeerJ. 2020 Aug 7;8:e9659. doi: 10.7717/peerj.9659. eCollection 2020.
6
Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With .布鲁里溃疡:固有免疫防御的功效可能是感染结局的关键决定因素。 (原文中“with”后面似乎缺失了病原体名称等关键信息)
Front Microbiol. 2020 May 25;11:1018. doi: 10.3389/fmicb.2020.01018. eCollection 2020.
7
Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway.全基因组关联研究在贝宁农村地区的布鲁里溃疡中强调了两个长非编码 RNA 和自噬途径的作用。
Commun Biol. 2020 Apr 20;3(1):177. doi: 10.1038/s42003-020-0920-6.
8
Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of infection.皮肤特异性抗体在感染的自发愈合过程中中和分枝杆菌内酯毒素。
Sci Adv. 2020 Feb 26;6(9):eaax7781. doi: 10.1126/sciadv.aax7781. eCollection 2020 Feb.
9
The immunology of other mycobacteria: M. ulcerans, M. leprae.其他分支杆菌的免疫学:溃疡分枝杆菌、麻风分枝杆菌。
Semin Immunopathol. 2020 Jun;42(3):333-353. doi: 10.1007/s00281-020-00790-4. Epub 2020 Feb 25.
10
Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.在低剂量小鼠挑战模型中针对溃疡分枝杆菌感染的疫苗特异性免疫反应。
Infect Immun. 2020 Feb 20;88(3). doi: 10.1128/IAI.00753-19.
在信息匮乏的情况下应对澳大利亚日益严重的布鲁里溃疡疫情:是时候做出紧急科学应对了。
Med J Aust. 2018 Apr 16;208(7):287-289. doi: 10.5694/mja17.00879.
4
Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.创伤愈合:澳大利亚分枝杆菌溃疡病患者接受抗生素治疗时延迟愈合的自然史和危险因素。
PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006357. doi: 10.1371/journal.pntd.0006357. eCollection 2018 Mar.
5
Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia.澳大利亚东南部溃疡分枝杆菌的严重程度和传播范围增加。
Emerg Infect Dis. 2018 Jan;24(1):58-64. doi: 10.3201/eid2401.171070. Epub 2018 Jan 17.
6
Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export.Sec61 阻断剂美拉诺菌素抑制抗原交叉呈递,而不依赖于内体到细胞质的输出。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5910-E5919. doi: 10.1073/pnas.1705242114. Epub 2017 Jul 5.
7
Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients.澳大利亚患者治疗溃疡分枝杆菌病期间的抗生素并发症。
Intern Med J. 2017 Sep;47(9):1011-1019. doi: 10.1111/imj.13511.
8
The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR.大环内酯毒素分枝杆菌内酯通过抑制mTOR促进布鲁里溃疡中Bim依赖性凋亡。
ACS Chem Biol. 2017 May 19;12(5):1297-1307. doi: 10.1021/acschembio.7b00053. Epub 2017 Mar 27.
9
Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection.分枝杆菌溃疡感染时自发性部分愈合的临床特征。
Open Forum Infect Dis. 2016 Feb 25;3(1):ofw013. doi: 10.1093/ofid/ofw013. eCollection 2016 Jan.
10
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.澳大利亚队列中对溃疡分枝杆菌病采用原发性口腔药物治疗的经验日益丰富。
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2692-5. doi: 10.1128/AAC.02853-15. Print 2016 May.